v3.25.2
CONSOLIDATED SCHEDULES OF INVESTMENTS (Parenthetical) 9
12 Months Ended
Jun. 30, 2024
Legere Pharmaceutical Holdings, Inc.  
Schedule of Investments [Line Items]  
Voting interest 4.98%
Legere Pharmaceutical Holdings, Inc. | Subsidiaries | Reportable Legal Entities  
Schedule of Investments [Line Items]  
Preferred equity ownership interest 38.95%